biostudies-literatureUnknown29(2)Ghosn J<h4>Objectives</h4>Persistent post-acute coronavirus disease 2019 (COVID-19) symptoms (PACSs) have been reported up to 6 months after hospital discharge. Herein we assessed the symptoms that persisted 12 months (M12) after admission for COVID-19 in the longitudinal prospective national French coronavirus disease cohort.<h4>Methods</h4>Hospitalized patients with a confirmed virological diagnosis of COVID-19 were enrolled. Follow-up was planned until M12 after admission. Associations between persistence of ≥3 PACSs at M12 and clinical characteristics at admission were assessed through logistic regression according to gender.<h4>Results</h4>We focused on participants enrolled between 24 January 2020 and 15 July 2020, to allow M12 follow-up. The M12 data were available for 737 participants. MeClinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases254.e7-254.e13https://www.ebi.ac.uk/biostudies/studies/S-EPMC9523945biostudies-literaturePrevalence of post-acute coronavirus disease 2019 symptoms twelve months after hospitalization in participants retained in follow-up: analyses stratified by gender from a large prospective cohort.PMC9523945Liegeon GBachelet DGandonniere CSMaillet MZucman DGoehringer FBani-Sadr FLaouenan CChirouze CMartin-Blondel GYelnik CSurgers LRoger PMCervantes-Gonzalez MLivrozet MLaunay OFrench COVID cohort Study Group and the French COVID cohort Investigators GroupPoissy JDuval XSenneville EGhosn JFaure KGousseff MDudoignon EJoseph CCabie ATattevin PfalsePrevalence of post-acute coronavirus disease 2019 symptoms twelve months after hospitalization in participants retained in follow-up: analyses stratified by gender from a large prospective cohort.<h4>Objectives</h4>Persistent post-acute coronavirus disease 2019 (COVID-19) symptoms (PACSs) have been reported up to 6 months after hospital discharge. Herein we assessed the symptoms that persisted 12 months (M12) after admission for COVID-19 in the longitudinal prospective national French coronavirus disease cohort.<h4>Methods</h4>Hospitalized patients with a confirmed virological diagnosis of COVID-19 were enrolled. Follow-up was planned until M12 after admission. Associations between persistence of ≥3 PACSs at M12 and clinical characteristics at admission were assessed through logistic regression according to gender.<h4>Results</h4>We focused on participants enrolled between 24 January 2020 and 15 July 2020, to allow M12 follow-up. The M12 data were available for 737 participants. Me2023-01-01T00:00:00Z2023 Feb2026-06-01T02:23:39.81Z2025-04-05T22:22:36.203ZS-EPMC95239453619184710.1016/j.cmi.2022.08.028